[go: up one dir, main page]

Lieberthal et al., 1997 - Google Patents

O-Raffinose Crosslinking Substantially Ameliorates the Vasoconstrictive and Nitric-Oxide-Inactivating Effects of Unmodified Human Hemoglobin in the Rat

Lieberthal et al., 1997

View PDF
Document ID
236654761594862629
Author
Lieberthal W
Fuhro R
Freedman J
Toolan G
Loscalzo J
Publication year

External Links

Snippet

We studied the hemodynamic effects of a 20 exchange transfusion with whole blood or highly purified human hemoglobin Ao. We compared the effects of unmodified hemoglobin with o-raffinose crosslinked oligomers of hemoglobin modified hemoglobin. The unmodified …
Continue reading at apps.dtic.mil (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41Porphyrin- or corrin-ring-containing peptides
    • A61K38/42Haemoglobins; Myoglobins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
US4529719A (en) Modified crosslinked stroma-free tetrameric hemoglobin
JP3568541B2 (en) Treatment of hemoglobin-containing erythrocytes with nitric oxide
Lieberthal et al. O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin
CA2752943C (en) A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
Patel Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes
Sehgal et al. Large-volume preparation of pyridoxylated hemoglobin with high P50
Young et al. Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys
MX2008014648A (en) Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute.
Simoni et al. ATP-adenosine-glutathione cross-linked hemoglobin as clinically useful oxygen carrier
Sakai et al. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days
Levy The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss
Mozzarelli et al. Chemistry and biochemistry of oxygen therapeutics: from transfusion to artificial blood
Vandegriff Blood substitutes: engineering the haemoglobin molecule
Scatena et al. O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier
Lieberthal et al. O-Raffinose Crosslinking Substantially Ameliorates the Vasoconstrictive and Nitric-Oxide-Inactivating Effects of Unmodified Human Hemoglobin in the Rat
Hess Blood substitutes for surgery and trauma: efficacy and toxicity issues
Juel et al. 2, 3-Diphosphoglycerate: its role in health and disease
Marchand et al. Resuscitation with increasing doses of diaspirin crosslinked hemoglobin in swine
Friedman et al. Hemoglobin solutions as blood substitutes
MESSMER Oxygen-carrying blood substitutes
Woodson et al. Effect of osmotic shrinking and swelling of red cells on whole blood oxygen affinity
Rudolph * HemAssist™: Development and Clinical Profile
Holowaychuk et al. Hemoglobin‐Based Oxygen Carrier Solutions
Nelson Clinical Profile
WO2024112490A2 (en) Nitrosyl-heme formulations for the treatment cardiovascular conditions, hemolysis, and the stabilization of cell-free heme molecules